LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
40 hedge funds and large institutions have $138M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 1 closing their positions.
Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
13
Reduced
11
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Adage Capital Partners
Boston,
Massachusetts
|
$14.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$3.44M |
| 3 |
3
Goldman Sachs
New York
|
$256K |
| 4 |
4
BlackRock
New York
|
$5.05M |
| 5 |
5
First Trust Advisors
Wheaton,
Illinois
|
$156K |
